LysoPC(22:1(13Z)/0:0)
|
Basic information |
| Metabolite name | LysoPC(22:1(13Z)/0:0) |
 | HMDB0010399 |
 |
C04230 |
 |
53480471 |
| Synonyms | LysoPC(22:1(13Z)) |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | LysoPC(22:1(13Z)/0:0) |
| HMDB0010399 |
|
C04230 |
|
53480471 |
| Synonyms | LysoPC(22:1(13Z)) |
| No. of studies | 2 |
|
Relationship between LysoPC(22:1(13Z)/0:0) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1098 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1098 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M1098 | Type2 | CUMS + L-theanine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Up |